Douwe Pons - Concepedia

Author

Douwe Pons

Leiden University Medical Center

Also Known As

D PONS, D Pons, D. PONS, D. Pons, Douwe Pons, M. Cambon

Publications

918

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center Amsterdam UMC Location University of Amsterdam Netherlands Heart Institute University Medical Center Groningen University Medical Center Utrecht

About

Douwe Pons is an author at Leiden University Medical Center specializing in medicine, vascular biology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	150
2	Public Health	3	3	58
3	Natural Sciences	1	1	21
4	Social Sciences	1	1	26
5	Biochemistry	1	1	26

Douwe Pons

Publications

633

Citations

H-Index

Page 1

	Year	Citations
Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy Rachel Lennon, Douwe Pons, Matthew A. Sabin, Nephrology Dialysis Transplantation	2009	143
Interleukin‐1β and interleukin‐1ra levels in nasal lavages during experimental rhinovirus infection in asthmatic and non‐asthmatic subjects Josephine de Kluijver, Katrien Grünberg, Douwe Pons, Clinical & Experimental Allergy	2003	54
Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and Mortality Stella Trompet, Douwe Pons, Sandip M. Kanse, Stroke Research and Treatment	2011	47
Genetic Variation in the Interleukin‐10 Gene Promoter and Risk of Coronary and Cerebrovascular Events Stella Trompet, Douwe Pons, Anton J.M. de Craen, Annals of the New York Academy of Sciences	2007	45
Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention Pascalle S. Monraats, Yue Fang, Douwe Pons, Expert Opinion on Therapeutic Targets	2010	43
Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention Pascalle S. Monraats, F. A. S. Kurreeman, Douwe Pons, Genes and Immunity InflammationPercutaneous Coronary InterventionCardiovascular DiseaseNew Risk MarkerImmunology	2006	37
Platelet receptor P2RY12 haplotypes predict restenosis after percutaneous coronary interventions Goran Rudež, Douwe Pons, Frank W.G. Leebeek, Human Mutation	2008	34
The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity Michael Etscheid, Lars Muhl, Douwe Pons, Thrombosis Research ThrombopoiesisProtein FunctionLow Pro-coagulant ActivityMedicineHematology	2012	33
p27 <sup>kip1</sup> –838C>A Single Nucleotide Polymorphism Is Associated With Restenosis Risk After Coronary Stenting and Modulates p27 <sup>kip1</sup> Promoter Activity Claudia M. van Tiel, Peter I. Bonta, Saskia Z.H. Rittersma, Circulation	2009	30
Efficacy and safety of haloperidol prophylaxis for delirium prevention in older medical and surgical at-risk patients acutely admitted to hospital through the emergency department: study protocol of a multicenter, randomised, double-blind, placebo-controlled clinical trial E.J.M. Schrijver, Oscar J. de Vries, Astrid Verburg, BMC Geriatrics	2014	28

Page 1